# B-cell Immunity to Influenza (SLVP017)- Year 1, 2009

> **NCT02133781** · PHASE4 · COMPLETED · sponsor: **Stanford University** · enrollment: 51 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Fluzone® 2009-2010 Formula
- **BIOLOGICAL:** FluMist® 2009-2010 Formula

## Key facts

- **NCT ID:** NCT02133781
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2018-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02133781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02133781, "B-cell Immunity to Influenza (SLVP017)- Year 1, 2009". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02133781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*